Hikma Pharmaceuticals PLC (HKMPF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 10 54 sessions, November 5, 2025 to November 4, 2026
- Largest daily move
- -13.2% close of February 26, 2026
- 1-month change
- +11.8% closing prices, September 21, 2026 to November 4, 2026
Company Description
Hikma Pharmaceuticals PLC (OTC: HKMPF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $4.9B.
HKMPF has gained 11.8% over the past month. The last closing price was $23.59.
This page collects what Stock Titan holds for HKMPF, including price data, latest news, and short interest trends.
Stock Performance
Hikma Pharmaceuticals PLC (HKMPF) closed at $23.59 on November 4, 2026. Over the past month, the price has gained 11.8%.
HKMPF Metrics & Rankings
Price returns through November 4, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Hikma Pharmaceuticals PLC has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include fda approval, partnership. View all HKMPF news →
SEC Filings
Short Interest History
Short interest in Hikma Pharmaceuticals PLC (HKMPF) currently stands at 154.5 thousand shares, up 5.7% from the previous reporting period, representing 0.1% of the float. Since November 2025, short interest has decreased by 63.7%.
Days to Cover History
Days to cover for Hikma Pharmaceuticals PLC (HKMPF) currently stands at 130.4 days, up 267.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 57.9%. Across the settlements charted above, it has ranged from 35.5 to 1000.0 days.
HKMPF Company Profile & Sector Positioning
Hikma Pharmaceuticals PLC (HKMPF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HKMPF often look at related companies in the same sector, including Hikma Pharms PLC (HKMPY), Sumitomo Pharma Co (SMDPY), Almirall SA (ALMRY), Kyowa Hakko Kogy (KYKOY), and Hypera SA (HYPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HKMPF's relative position within its industry.